Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
Status:
Not yet recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
This clinical trial is focused on determining whether biological signatures of target
engagement by a Centella asiatica water extract product administered orally for 6 weeks can
be measured in comparison to placebo. This study will also assess the safety and tolerability
of the Centella asiatica water extract product.